• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

June 21-22, 2016 - Public Meeting

Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria.

The June public meeting was dedicated to presentations from federal and non-federal stakeholders surrounding topic areas related to incentives for the development of vaccines, diagnostics, and therapeutics. The topic of the environment and its intersection with antibiotic-resistance was also discussed.

Agenda

Public Agenda

Webcast Information

Archived Webcast

Meeting Documents

Meeting Summary

March 2016 - Letter to the PACCARB Chair and Vice Chair

Presentations

Incentives and USG Experience

Incentives – International Experience

Incentives – Industry Experience

Plasmid-Mediated Colistin Resistance – U.S. Government Findings and Response

Antibiotic Resistance in the Healthcare Environment

FDA’s Guidance for Industry #213

Drivers of AMR and Antibiotic Metabolites in the Environment

Environmental Compartments of AMR and Antibiotic Metabolites

Environmental AMR Surveillance and USG Activities

Notice

Federal Register Notice

Content created by Assistant Secretary for Health (ASH)
Content last reviewed on July 24, 2017